Skip to main content
Log in

Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine

  • Paper
  • Published:
International Journal of Obesity Submit manuscript

Abstract

OBJECTIVE: To investigate the pharmacological mechanisms underlying the induction of thermogenesis by Metabolite 2 (M2; BTS 54 505), a major pharmacologically active metabolite of the anti-obesity drug, sibutramine.

DESIGN: Adult female Wistar rats were treated with M2 or vehicle, with or without various monoamine receptor antagonists, prazosin, RS79948, metergoline, propranolol and (+)butaclamol.

MEASUREMENTS: Colonic temperature and food intake at room temperature (21±1°C), thermoregulatory behavioural response, operant responding for exogenous heat at −8°C and oxygen consumption at thermoneutrality (29°C).

RESULTS: M2 (10 mg/kg, p.o.) significantly increased colonic temperature during the 4.5 h period following drug administration. This effect was abolished by the non-selective 5-HT receptor antagonist, metergoline (1 mg/kg, p.o.), and α1-adrenoceptor antagonist, prazosin (1 mg/kg, p.o.), measured at 1.5–2.5 h post-M2 administration, and was partially antagonized by each antagonist at 3.5–4.5 h. The non-selective β-adrenoceptor antagonist, propranolol (1 mg/kg, p.o.), had no effect on the M2-induced increase in colonic temperature, whereas at 20 mg/kg (p.o.), propranolol partially inhibited the effect of M2 on colonic temperature. By contrast, the selective α2-adrenoceptor antagonist, RS79948 (1 mg/kg, p.o.), and the D2/D1 receptor antagonist, (+)butaclamol (200 µg/kg, p.o.), did not alter the effect of M2 on colonic temperature. In the thermoregulatory study, M2 (10 mg/kg, i.p.)-treated rats required significantly less radiant heat at −8°C to maintain body temperature, and this effect was not affected by the D2/D1 receptor antagonist (+)butaclamol (100 µg/kg−1, i.p.). The hypophagia induced by M2 (10 mg/kg) measured up to 24 h was partially antagonized by the α1-adrenoceptor antagonist, prazosin, whereas metergoline, RS79948, propranolol and (+)butaclamol had no effect on M2-induced hypophagia.

CONCLUSION: It is concluded that 5-HT, α1- and β3-adrenoceptors are involved in the induction of thermogenesis by M2, whereas the hypophagic effect is mainly mediated via α1-adrenoceptors. These findings are consistent with M2 increasing 5-HT and noradrenaline tone via potent reuptake inhibition which subsequently results in increased efferent sympathetic activity to brown adipose tissue (BAT).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Stock MJ . Sibutramine: a review of the pharmacology of a novel anti-obesity agent Int J Obes Relat Metab Disord 1997 21 (Suppl 1): S25–S29.

    CAS  PubMed  Google Scholar 

  2. Heal DJ, Cheetham SC . The pharmacology of sibutramine, the first serotonin and noradrenaline reuptake inhibitor to be developed for the treatment of obesity Lettre Pharmac 1997 11 (Suppl 10): 3–8.

    Google Scholar 

  3. Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC . Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine Int J Obes Relat Metab Disord 1998 22 (Suppl 1): S18–S28.

    CAS  PubMed  Google Scholar 

  4. Cheetham SC, Viggers JA, Slater NA, Heal DJ, Buckett WR . [3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]-5-HT uptake: effect of administration of various antidepressant treatments Neuropharmacology 1993 32: 737–743.

    Article  CAS  Google Scholar 

  5. Cheetham SC, Viggers JA, Butler SA, Prow MR, Heal DJ . [3H]Nisoxetine—a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments Neuropharmacology 1996 35: 63–70.

    Article  CAS  Google Scholar 

  6. Luscombe GP, Hopcroft RH, Thomas PC, Buckett WR . The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochloride Neuropharmacology 1989 28: 129–134.

    Article  CAS  Google Scholar 

  7. Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ . Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rats Br J Pharmac 1997 121: 1613–1618.

    Article  CAS  Google Scholar 

  8. Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, Heal DJ . Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat Br J Pharmac 1997 121: 1758–1762.

    Article  CAS  Google Scholar 

  9. Grignaschi G, Fanelli E, Scagnol I, Samanin R . Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats Br J Pharmac 1999 127: 1190–1194.

    Article  CAS  Google Scholar 

  10. Halford JCG, Heal DJ, Blundell JE . Effects in the rats of sibutramine on food intake and the behavioural satiety sequence Br J Pharmac 1995 114: 387P.

    Google Scholar 

  11. Pleasance IM, Mitchell JC, Jackson HC, Heal DJ . Observational analysis of the effects of sibutramine and phentermine on food intake Int J Obes Relat Metab Disord 2000 24 (Suppl 1): P407.

    Google Scholar 

  12. Fantino M, Martel P, Souquet AM, Wieteska L, Brondel L, Courcier S . Decrease of food intake and weight loss induced by sibutramine in the rat Obes Res 1995 3 (Suppl 4): 628S.

    Google Scholar 

  13. Weintraub M, Rubio A, Golik A, Byrne L, Scheinbaum ML . Sibutramine in weight control; a dose-ranging efficacy study Clin Pharmac Ther 1991 50: 330–337.

    Article  CAS  Google Scholar 

  14. Apfelbaum M, Vague P, Zeigler O, Hanotin C, Thomas F, Leutenegger E . Long-term maintenance of weight loss after a very low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine Am J Med 1999 106: 179–184.

    Article  CAS  Google Scholar 

  15. James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WHM, Van Gaal LF . Effect of sibutramine on weight maintenance after weight loss: a randomised trial Lancet 2000 356: 2119–2125.

    Article  CAS  Google Scholar 

  16. Connoley IP, Heal DJ, Stock MJ . A study in rats of the effects of sibutramine on food intake and thermogenesis Br J Pharmac 1995 114: 388P.

    Google Scholar 

  17. Connoley IP, Liu YL, Frost I, Reckless IP, Heal DJ, Stock MJ . Thermogenic effects of sibutramine and its metabolites Br J Pharmac 1999 126: 1487–1495.

    Article  CAS  Google Scholar 

  18. Carlisle HJ, Stock MJ . Effect of conventional (mixed β1/β2) and novel (β3) adrenergic agonists on thermoregulatory behavior Pharmac Biochem Behav 1991 40: 249–254.

    Article  CAS  Google Scholar 

  19. Hjorth S, Clark D, Carlsson A . Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations Life Sci 1985 37: 673–684.

    Article  CAS  Google Scholar 

  20. Sakaguchi T, Bray GA . Effect of norepinephrine, serotonin and tryptophan on the firing of sympathetic nerves Brain Res 1989 492: 271–280.

    Article  CAS  Google Scholar 

  21. Steiner G, Evans S . Effect of serotonin on BAT and on its sympathetic neurons Am J Physiol 1976 231: 34–39.

    Article  CAS  Google Scholar 

  22. Plata-Salaman CR . Hypothalamus and the control of feeding: fifteen decades of direct association Nutrition 1998 14: 67–70.

    Article  CAS  Google Scholar 

  23. Buckett WR, Luscombe GP, Thomas PC . BTS 54 524—an approach to a rapid acting antidepressant In: Briley M, Fillion G (eds.) New Concepts in Depression London: Macmillan 1987 pp 167–172.

    Google Scholar 

  24. Hoyer D . Functional correlates of serotonin 5-HT1 recognition sites J Receptor Res 1988 8: 59–81.

    Article  CAS  Google Scholar 

  25. Hoyer D, Waeber C, Schoeffter P, Palacios JM, Dravid A . 5-HT1c receptor-mediated stimulation of inositol phosphate production in pig choroid plexus: a pharmacological characterization Naunyn-Schmiedeberg's Arch Pharmac 1989 339: 252–258.

    Article  CAS  Google Scholar 

  26. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphreys PPA . International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmac Rev 1996 46: 157–203.

    Google Scholar 

  27. Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ . Receptor binding profile of R 41468, a novel antagonist at 5-HT2 receptors Life Sci 1981 28: 1015–1022.

    Article  CAS  Google Scholar 

  28. Carlisle HJ, Stock MJ . Potentiation of thermoregulatory responses to isoproterenol by β-adrenergic antagonists Am J Physiol 1992 263: R915–R923.

    CAS  PubMed  Google Scholar 

  29. Liu Y-L, Stock MJ . Acute effects of the β3-adrenoceptor agonist BRL35135 on tissue glucose utilization Br J Pharmac 1995 114: 888–894.

    Article  CAS  Google Scholar 

  30. Hume SP, Ashworth S, Lammertsma AA, Opacka-Juffry J, Law MP, McCarron JA, Clark RD, Nutt DJ, Pike VW . Evaluation in rat of RS-79948-197 as a potential PET ligand for central α2-adrenoceptors Eur J Pharmac 1996 317: 67–73.

    Article  CAS  Google Scholar 

  31. Uhlen S, Dambrova M, Nasman J, Schioth HB, Gu Y, Wikberg-Matsson A, Wikberg JE . [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine Eur J Pharmac 1998 343: 93–101.

    Article  CAS  Google Scholar 

  32. Galitzky J, Vermonel M, Lafontan M, Montastruc P, Berlan M . Thermogenic and lipolytic effect of yohimbine in the dog Br J Pharmac 1991 104: 514–518.

    Article  CAS  Google Scholar 

  33. Laverty R, Taylor KM . Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system Br J Pharmac 1969 35: 253–264.

    Article  CAS  Google Scholar 

  34. Drew GM, Gower AJ, Marriott AS . α2-Adrenoceptors mediate clonidine-induced sedation in the rat Br J Pharmac 1979 67: 133–141.

    Article  CAS  Google Scholar 

  35. Zhao J, Cannon B, Nedergaard J . α1-Adrenergic stimulation potentiates the thermogenic action of β3-adrenoceptor-generated cAMP in brown fat cells J Biol Chem 1997 272: 32847–32856.

    Article  CAS  Google Scholar 

  36. Skill MJ, Dickinson K, Jones RB, Heal DJ . Thermogenic effects of repeated sibutramine treatment in female rats Int J Obes Relat Metab Disord 2000 24 (Suppl 1): S135.

    Google Scholar 

  37. Burlet C, Stricker-Krongrad A, Souquet AM, Courcier S . Effects of chronic sibutramine treatment on feeding behaviour and body weight in adult rats Obes Res 1995 3: 627S.

    Article  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Knoll Ltd Research & Development (Nottingham) for their financial support and for providing M2.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y-L Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, YL., Heal, D. & Stock, M. Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine. Int J Obes 26, 1245–1253 (2002). https://doi.org/10.1038/sj.ijo.0802062

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802062

  • Springer Nature Limited

Keywords

This article is cited by

Navigation